Novel Treatment Advances
and Approaches in Management of HIV
A continuing medical
education activity sponsored by NAMCP and AAMCN
This webinar series will provide critical updates on the advances in
the management of HIV
These are archives of live webinars held between December 9 to
December 18, 2020.
If you participated in any of the live webinars, you are not
eligible
to claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all 3 or in order.
This activity is valid from January 1, 2021 to January 1, 2023
This
series is supported by educational grants from
ViiV Healthcare
Audience:
This activity is intended for healthcare professionals practicing in managed
care environments.
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
certificate.
Description:
HIV is a lentivirus that causes HIV infection and
over time acquired immunodeficiency syndrome (AIDS). HIV infection leads to low
levels of CD4+ T cells through a number of specific mechanisms. When CD4+ T cell
numbers decline below a critical level, cell-mediated immunity is lost, and the
body becomes progressively more susceptible to opportunistic infections. The CDC
estimates that 1,218,400 people in the US aged 13 years and older are living
with HIV infection and an estimated 6,955 people died in 2019. Fortunately,
several new therapies have become available recently, and more are set to become
available soon. |
Integrating the Latest Data and Guidelines in the Management of
HIV: Strategies for Optimizing Clinical and Economic Outcomes
- Examine the clinical burden of HIV, including factors that contribute to
poor prognosis and increased costs
- Compare and contrast new and emerging antiretroviral therapies (ART)
based on the latest evidence for their efficacy, safety, and adherence
potential
- Apply recent clinical trial data to identify appropriate patient
populations for new and emerging 2-drug regimens, including long-acting ART
- Explore the role of newer therapies for heavily treatment-experienced (HTE)
adults with multidrug-resistant HIV-1 infection
- Evaluate patient-specific factors, including age, comorbidities,
concomitant medications, and adherence challenges, in making decisions about
HIV therapy selection
Physician, Nursing and CMCN credits valid to
January 1, 2023 |
Comparative Effectiveness and Payer-Provider Coordination in
HIV: What Does Managed Care Need to Know About New and Emerging
Therapies?
- Examine the economic burden of HIV, including factors that contribute to
poor prognosis and increased costs
- Compare and contrast new and emerging antiretroviral therapies (ART)
based on the latest evidence for their efficacy, safety, and adherence
potential
- Assess approaches currently utilized by third party payers to manage
costs associated with the care of patients with HIV
- Discuss the managed care considerations of new and emerging therapies by
exploring where these agents may fit into current HIV management paradigm
- Align managed care decisions with updated guidelines and evidence on
initial ART selection and ART switching based on patient-specific factors,
including comorbidities, concomitant medications, age, adherence, and
patient preferences
Physician, Nursing and CMCN credits valid to
January 1, 2023 |